FP-Biotin: Activity-Based Probe for Serine Hydrolases

FP-biotin is a fluorophosphonate-tagged biotin probe that covalently and irreversibly modifies the active-site serine of serine hydrolases, enabling their selective capture and identification from complex biological samples.

Probe Class

Fluorophosphonate (FP) activity-based probe

Primary Target Enzyme Class

Serine hydrolases (serine proteases and serine lipases/esterases)

Reactive Warhead

Fluorophosphonate electrophile reacting with catalytic serine

Detection/Enrichment Tag

Biotin — enables streptavidin-based pull-down and western blot detection

Key Application

Competitive and standard activity-based protein profiling (ABPP)

Sample Compatibility

Cell lysates, tissue homogenates, live cells (membrane and soluble proteomes)

SKU

F1288601

What Is FP-Biotin and How Does It Work?

FP-biotin belongs to the class of activity-based probes (ABPs) designed for activity-based protein profiling (ABPP). The molecule consists of three functional components: (1) a fluorophosphonate (FP) warhead that mimics natural substrates of serine hydrolases; (2) a linker that provides appropriate spacing and solubility; and (3) a biotin affinity tag that allows downstream detection and enrichment via streptavidin-coated beads or blotting membranes.

The FP warhead reacts selectively and irreversibly with the nucleophilic catalytic serine residue present in the active site of serine hydrolases. This reaction proceeds through a covalent phosphonylation mechanism, inactivating the enzyme and simultaneously labeling it with the biotin tag. Critically, only catalytically active enzymes are labeled; zymogen precursors, inhibitor-bound, or otherwise inactive forms are not modified. This activity dependence is the central advantage of FP-biotin over antibody-based detection methods, which cannot distinguish active from inactive enzyme pools.

Applications in Activity-Based Protein Profiling (ABPP)

FP-biotin is most commonly used in two complementary ABPP formats:

1. Standard (Gel-Based) ABPP: Proteome samples are incubated with FP-biotin, separated by SDS-PAGE, transferred to membrane, and probed with streptavidin-HRP or streptavidin-fluorophore. The resulting banding pattern provides a snapshot of active serine hydrolases in the sample. Changes in band intensity between experimental and control conditions report on differential enzyme activity.

2. Competitive ABPP: Samples are pre-treated with a candidate inhibitor before FP-biotin addition. Inhibitors that occupy the active site block FP-biotin labeling, causing a reduction or disappearance of the corresponding band. This approach enables inhibitor selectivity profiling across entire serine hydrolase families in a single experiment, without the need for individual substrate assays.

3. Proteomics-Compatible Enrichment: Biotinylated enzyme targets can be pulled down with streptavidin beads, digested with trypsin, and analyzed by LC-MS/MS for global serine hydrolase activity profiling, including discovery of novel targets.

FP-biotin has been applied to study enzyme activity in mammalian cell lines, primary tissues, mouse models, and ex vivo patient-derived samples across fields including neuroscience, immunology, cancer biology, and drug discovery.

Sample Preparation and Protocol Considerations

Optimal FP-biotin labeling requires attention to several protocol parameters:

• Protein concentration: Typical labeling reactions use proteome samples at 1–2 mg/mL total protein, though this should be optimized for each sample type. Consistent protein loading is essential for comparative experiments.
• Probe concentration and incubation time: FP-biotin is typically used in the low-micromolar range. Concentration and time should be optimized to achieve complete labeling without excessive non-specific background. Common starting conditions are 1–5 µM probe for 30–60 minutes at room temperature, though published protocols may vary.
• Solvent and vehicle controls: FP-biotin is typically dissolved in DMSO. Include matched DMSO vehicle controls. Final DMSO concentration in the reaction should generally be kept at or below 1% to avoid proteome perturbation.
• Quenching and sample preparation: Reactions are quenched by adding SDS-PAGE loading buffer (denaturing conditions) or by dilution and bead-based enrichment for mass spectrometry workflows.
• Storage: Store FP-biotin as directed on the product datasheet. Avoid repeated freeze-thaw cycles. Prepare fresh working stocks from concentrated DMSO solutions where possible.

For competitive ABPP, inhibitor pre-incubation is typically performed for 30–60 minutes prior to FP-biotin addition. Inhibitor concentrations should span a range sufficient to generate dose-response data.

Interpreting Results and Troubleshooting

When analyzing FP-biotin labeling data, keep the following points in mind:

Band/signal interpretation: Each labeled band represents an active serine hydrolase. Bands that disappear or diminish in competitive ABPP experiments indicate that the tested compound engages that enzyme's active site. Changes in labeling between biological conditions (e.g., drug-treated vs. untreated, disease vs. healthy tissue) reflect real differences in enzyme activity states, which may not correlate with protein abundance as measured by conventional proteomics.

Common troubleshooting scenarios:

• Weak or absent signal: Check probe integrity (freshness, storage conditions), protein concentration, and labeling duration. Ensure streptavidin detection reagent is active.
• High background: Reduce probe concentration, shorten incubation time, or optimize wash conditions for streptavidin pull-down. Endogenous biotin in samples (e.g., from mitochondria-rich tissues) can contribute background; consider pre-clearing with streptavidin beads.
• Unexpected labeling pattern changes: Verify that inhibitor or treatment vehicle does not directly interfere with the FP-biotin reaction. Confirm consistent sample handling across conditions.

Comparison with published serine hydrolase ABPP datasets can assist in annotating labeled bands, particularly for complex tissue proteomes.

Frequently asked questions

What enzyme class does FP-biotin label?

FP-biotin selectively labels serine hydrolases, a large enzyme superfamily that includes serine proteases (such as trypsin-family proteases) and serine lipases and esterases. The fluorophosphonate warhead reacts specifically with the nucleophilic catalytic serine in the active site of these enzymes, and only active (non-inhibited, non-zymogen) forms are labeled.

How is FP-biotin different from fluorophosphonate-rhodamine (FP-rhodamine) probes?

Both FP-biotin and FP-rhodamine probes target the same enzyme class using the same fluorophosphonate warhead. The key difference is in the reporting tag: FP-biotin carries a biotin tag enabling streptavidin-based enrichment for mass spectrometry proteomics workflows, while FP-rhodamine carries a fluorescent rhodamine tag for direct in-gel fluorescence visualization. Researchers often use FP-rhodamine for rapid gel-based activity profiling and FP-biotin when target identification or enrichment is required.

Can FP-biotin be used in live-cell labeling experiments?

Yes, FP-biotin can be applied to live cells or added to cell culture medium to label serine hydrolases in intact cellular contexts, enabling profiling of both membrane-associated and secreted enzyme activities. However, cell permeability and probe delivery conditions should be optimized for each cell type, and appropriate controls for cytotoxicity and non-specific effects should be included.

How should FP-biotin stocks be prepared and stored?

FP-biotin is typically dissolved in anhydrous DMSO to prepare a concentrated stock solution. Stocks should be stored as recommended on the product datasheet (typically at –20 °C or –80 °C, protected from light and moisture). Avoid repeated freeze-thaw cycles by aliquoting into single-use volumes. Always consult the product-specific datasheet (SKU F1288601) for confirmed storage and handling conditions.

What controls are recommended when using FP-biotin?

Recommended controls include: (1) a DMSO vehicle control matched to the experimental DMSO concentration; (2) a boiled/heat-denatured proteome control to confirm that labeling is activity-dependent; (3) for competitive ABPP, a no-inhibitor control to establish baseline labeling intensity; and (4) streptavidin detection reagent controls to confirm specific biotin-streptavidin signal. Including these controls ensures that observed differences in labeling are attributable to genuine changes in serine hydrolase activity.

References

1. Cravatt BF, Wright AT, Kozarich JW. Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annu Rev Biochem. 2008;77:383-414. doi:10.1146/annurev.biochem.75.101304.124125
2. Jessani N, Cravatt BF. The development and application of methods for activity-based protein profiling. Curr Opin Chem Biol. 2004;8(1):54-59. doi:10.1016/j.cbpa.2003.11.004
3. Liu Y, Patricelli MP, Cravatt BF. Activity-based protein profiling: the serine hydrolases. Proc Natl Acad Sci USA. 1999;96(26):14694-14699. doi:10.1073/pnas.96.26.14694
4. Bachovchin DA, Cravatt BF. The pharmacological landscape and therapeutic potential of serine hydrolases. Nat Rev Drug Discov. 2012;11(1):52-68. doi:10.1038/nrd3620

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.